The TANTALUS® II for the Treatment of Type 2 Diabetes (Crossover)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
MetaCure (USA), Inc.
ClinicalTrials.gov Identifier:
NCT01303302
First received: February 23, 2011
Last updated: May 27, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)